PMAM
CAI

Picton Mahoney Asset Management’s Caris Life Sciences CAI Stock Holding History

Picton Mahoney Asset Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.99M Buy
278,977
+60,672
+28% +$1.33M 0.04% 361
2025
Q4 		$5.89M Buy
218,305
+212,095
+3,415% +$5.97M 0.05% 294
2025
Q3 		$188K Buy
+6,210
New +$198K ﹤0.01% 668

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Picton Mahoney Asset Management's CAI Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its Caris Life Sciences (CAI) stake by 28% in Q1 2026, buying an estimated $1.33M and bringing the position to 278,977 shares worth $4.99M. The position accounts for 0.04% of the portfolio, ranked #361.

Picton Mahoney Asset Management first reported a position in CAI in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.89M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Picton Mahoney Asset Management held 278,977 shares of Caris Life Sciences worth $4.99M as of Q1 2026.
  • Picton Mahoney Asset Management bought 60,672 Caris Life Sciences shares in Q1 2026, an estimated $1.33M.
  • Caris Life Sciences made up 0.04% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #361 holding.
  • Picton Mahoney Asset Management first reported a position in Caris Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • Picton Mahoney Asset Management's Caris Life Sciences position peaked at $5.89M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.